b'OncoVerity Fighting Cancer with Data and Wisdom OncoVerity is a cutting-edge biotech company using a computationalStrategic Life Sciences biology platform to better the lives of patients battling cancer. OncoVerityPartnerships Achieveis addressing a fundamental challenge in cancer treatmentthe diverseGreater Successnature of cancer cellsby using single-cell analysis technology and machine learning to advance transformative cancer therapies. An important Fitzsimons Innovation Community Just like every person is different, every cancer is different, and everypartner from their beginning, Colorado BioScience cell within a cancer is different. OncoVerity is using single-cell analysisAssociation (CBSA) advances Colorados life sciences technology and machine learning to decode differences. ecosystem by building a collaborative, pro-innovation business environment. Max Colao, CEO, OncoVerity CBSA expands access to capital, offers education and networking opportunities for their members, and READ SPOTLIGHT advocates for life sciences companies by creating strong partnerships with policymakers and business leaders. One of the many ways they provide these opportunities is through the Rocky Mountain Life Sciences Investor & Partnering Conference. The biannual CBSA Rocky Mountain Life Sciences RheumaGen + ClinImmune Investor & Partnering Conference took place in September 2024 in Breckenridge, Colorado. The Revolutionizing the Field of Autoimmunitygoal of this event is to connect investors and RheumaGen is a cell and gene therapy company developing therapiesstrategic partners from across the country with with the potential to cure rheumatoid arthritis (RA) and other majorhigh-growth companies from Colorado and the autoimmune diseases like multiple sclerosis (MS), juvenile diabetes (T1D),Rocky Mountain West. Since this conference began, ankylosing spondylitis, and celiac disease. Fitzsimons Innovation Community has been a proud key sponsor, which made it even more exciting Were not interested in incremental improvements. We seek cures, we seekthis year to have these six Community members remission, we seek to relieve the burden that these patients and their familiesparticipating: EnteroTrack, GelSana, Onconaut have carried for so longbecause that is the potential of HLA gene editing.Therapeutics, RheumaGen (in partnership with Richard Freed, CEO, RheumaGen ClinImmune Cell and Gene Therapy), TrAMPoline Pharma, and Vona Oncology.READ SPOTLIGHT READ MOREVona OncologyProviding New Hope for Patients with Aggressive CancersVona Oncology is an early clinical stage bio-pharmaceutical company developing targeted therapeutics to treat aggressive cancers such as triple-negative breast cancer (TNBC), ovarian cancer, and melanoma. Vona Oncology has an innovative, novel small molecule that is very efficaciousAt the Rocky Mountain Life Sciences Investor and Partnering with little toxicity to improve standard of care. Conference in Breckenridge, Thomas Smith, CFO, Fitzsimons Innovation Community, had the honor of introducing the keynote speaker, Siri Lindley. Siri is a world champion triathlete, business Vona is the Icelandic word for hope. Our mission is to provide new hope forperformance coach, former resident of Boulder, and one of Tony patients with aggressive cancers where novel therapies are needed.Robbins top motivational speakers, who credits a clinical trial at CU Anschutz for saving her life.Jim Lambert, Ph.D., President, and Founder, Vona OncologyREAD SPOTLIGHT17'